Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer
2626.5000 35.20 (1.36%)
NSE Jul 11, 2025 15:31 PM
Volume: 236.9K
 

logo
Ajanta Pharma Ltd.
30 Jul 2021
2626.50
1.36%
Motilal Oswal
Ajanta Pharma (AJP) delivered 1QFY22 earnings marginally below our expectation. Robust growth in Domestic Formulation (DF) / Branded Generics (Africa) was offset by moderate growth in US / Branded Generics (Asia) and enhanced opex towards marketing and promotional activities. AJP is on track to outperform in the Branded Generics segment across DF/Asia/Africa and build a product pipeline for the US market. We tweak our estimates for FY22E/FY23E, factoring in a) a better outlook for the Pain Management, Opthal, and Derma therapies in the DF segment,...
Ajanta Pharma Ltd. has an average target of 3022.00 from 5 brokers.
More from Ajanta Pharma Ltd.
Recommended